Skip to main content
Erschienen in: Alzheimer's Research & Therapy 6/2013

01.12.2013 | Debate

High adiposity: risk factor for dementia and Alzheimer’s disease?

verfasst von: Deborah R Gustafson, José A Luchsinger

Erschienen in: Alzheimer's Research & Therapy | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Higher levels of total and central adiposity, measured as higher body mass index (BMI) (in kilograms per square meter), waist circumference, or waist-to-hip ratio, have been associated with late-onset Alzheimer’s disease (AD). However, some epidemiologic studies do not support this association, and potential underlying biological mechanisms that provide biological plausibility are not clear in terms of providing direct links to adipose tissue. Studies linking adiposity to AD have considered adiposity measures from mid-life and late-life. Given an evolving background trajectory of BMI that exists over the life course and the influence of dementia processes on BMI, results have been conflicting depending on when BMI is measured in relationship to clinical AD onset. This has made interpretation of the BMI-AD literature difficult. This debate will briefly review the epidemiologic evidence for and against an association between higher adiposity and AD, issues of timing of the adiposity measure in relation to AD onset, potential biological mechanisms for observed associations, and explanations for conflicting evidence.
Literatur
1.
Zurück zum Zitat Gustafson DR, Rothenberg E, Blennow K, Steen B, Skoog I: An 18-year follow up of overweight and risk for Alzheimer’s disease. Arch Intern Med. 2003, 163: 1524-1528. 10.1001/archinte.163.13.1524.CrossRefPubMed Gustafson DR, Rothenberg E, Blennow K, Steen B, Skoog I: An 18-year follow up of overweight and risk for Alzheimer’s disease. Arch Intern Med. 2003, 163: 1524-1528. 10.1001/archinte.163.13.1524.CrossRefPubMed
2.
Zurück zum Zitat Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K: Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005, 330: 1360-1364. 10.1136/bmj.38446.466238.E0.PubMedCentralCrossRefPubMed Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K: Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005, 330: 1360-1364. 10.1136/bmj.38446.466238.E0.PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Whitmer RA, Gunderson EP, Quesenberry CP, Zhou J, Yaffe K: Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 2007, 4: 103-109. 10.2174/156720507780362047.CrossRefPubMed Whitmer RA, Gunderson EP, Quesenberry CP, Zhou J, Yaffe K: Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 2007, 4: 103-109. 10.2174/156720507780362047.CrossRefPubMed
4.
Zurück zum Zitat Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K: Central obesity and increased risk of dementia more than three decades later. Neurology. 2008, 71: 1057-1064. 10.1212/01.wnl.0000306313.89165.ef.CrossRefPubMed Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K: Central obesity and increased risk of dementia more than three decades later. Neurology. 2008, 71: 1057-1064. 10.1212/01.wnl.0000306313.89165.ef.CrossRefPubMed
5.
Zurück zum Zitat Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O’Meara ES, Longstreth WT, Luchsinger JA: Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009, 66: 336-342. 10.1001/archneurol.2008.582.PubMedCentralCrossRefPubMed Fitzpatrick AL, Kuller LH, Lopez OL, Diehr P, O’Meara ES, Longstreth WT, Luchsinger JA: Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol. 2009, 66: 336-342. 10.1001/archneurol.2008.582.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA, Cache County Investigators: Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord. 2006, 20: 93-100. 10.1097/01.wad.0000213814.43047.86.CrossRefPubMed Hayden KM, Zandi PP, Lyketsos CG, Khachaturian AS, Bastian LA, Charoonruk G, Tschanz JT, Norton MC, Pieper CF, Munger RG, Breitner JC, Welsh-Bohmer KA, Cache County Investigators: Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord. 2006, 20: 93-100. 10.1097/01.wad.0000213814.43047.86.CrossRefPubMed
7.
Zurück zum Zitat Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A: Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005, 62: 1556-1560. 10.1001/archneur.62.10.1556.CrossRefPubMed Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A: Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005, 62: 1556-1560. 10.1001/archneur.62.10.1556.CrossRefPubMed
8.
Zurück zum Zitat Rosengren A, Skoog I, Gustafson D, Wilhelmsen L: Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med. 2005, 165: 321-326. 10.1001/archinte.165.3.321.CrossRefPubMed Rosengren A, Skoog I, Gustafson D, Wilhelmsen L: Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med. 2005, 165: 321-326. 10.1001/archinte.165.3.321.CrossRefPubMed
9.
Zurück zum Zitat Chiang CJ, Yip PK, Wu SC, Lu CS, Liou CW, Liu HC, Liu CK, Chu CH, Hwang CS, Sung SF, Hsu YD, Chen CC, Liu SI, Yan SH, Fong CS, Chang SF, You SL, Chen CJ: Midlife risk factors for subtypes of dementia: a nested case–control study in Taiwan. Am J Geriatr Psychiatry. 2007, 15: 762-771. 10.1097/JGP.0b013e318050c98f.CrossRefPubMed Chiang CJ, Yip PK, Wu SC, Lu CS, Liou CW, Liu HC, Liu CK, Chu CH, Hwang CS, Sung SF, Hsu YD, Chen CC, Liu SI, Yan SH, Fong CS, Chang SF, You SL, Chen CJ: Midlife risk factors for subtypes of dementia: a nested case–control study in Taiwan. Am J Geriatr Psychiatry. 2007, 15: 762-771. 10.1097/JGP.0b013e318050c98f.CrossRefPubMed
10.
Zurück zum Zitat Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R: Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord. 2012, 26: 101-105. 10.1097/WAD.0b013e318222f0d4.PubMedCentralCrossRefPubMed Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R: Central obesity in the elderly is related to late-onset Alzheimer disease. Alzheimer Dis Assoc Disord. 2012, 26: 101-105. 10.1097/WAD.0b013e318222f0d4.PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Gustafson DR: Adiposity and cognitive decline: underlying mechanisms. J Alzheimers Dis. 2012, 30: S97-S112.PubMed Gustafson DR: Adiposity and cognitive decline: underlying mechanisms. J Alzheimers Dis. 2012, 30: S97-S112.PubMed
12.
Zurück zum Zitat Luchsinger JA, Gustafson DR: Adiposity, type 2 diabetes, and Alzheimer’s disease. J Alzheimers Dis. 2009, 16: 693-704.PubMedCentralPubMed Luchsinger JA, Gustafson DR: Adiposity, type 2 diabetes, and Alzheimer’s disease. J Alzheimers Dis. 2009, 16: 693-704.PubMedCentralPubMed
13.
Zurück zum Zitat Arnoldussen IA, Kiliaan AJ, Gustafson DR: Obesity and dementia: adipokines interact with the brain. Eur J Neuropsychopharmacology. in press Arnoldussen IA, Kiliaan AJ, Gustafson DR: Obesity and dementia: adipokines interact with the brain. Eur J Neuropsychopharmacology. in press
14.
Zurück zum Zitat Stewart R, Masaki K, Xue Q-L, Peila R, Petrovitch H, White LR, Launer LJ: A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2005, 62: 55-60. 10.1001/archneur.62.1.55.CrossRefPubMed Stewart R, Masaki K, Xue Q-L, Peila R, Petrovitch H, White LR, Launer LJ: A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol. 2005, 62: 55-60. 10.1001/archneur.62.1.55.CrossRefPubMed
15.
Zurück zum Zitat Gustafson D, Bäckman K, Joas E, Waern M, Östling S, Guo X, Skoog I: A 37-year longitudinal follow-up of body mass index and dementia in women. J Alzheimers Dis. 2012, 28: 162-171. Gustafson D, Bäckman K, Joas E, Waern M, Östling S, Guo X, Skoog I: A 37-year longitudinal follow-up of body mass index and dementia in women. J Alzheimers Dis. 2012, 28: 162-171.
16.
Zurück zum Zitat Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L: Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc. 2008, 56: 111-116. 10.1111/j.1532-5415.2007.01458.x.CrossRefPubMed Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L: Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc. 2008, 56: 111-116. 10.1111/j.1532-5415.2007.01458.x.CrossRefPubMed
17.
Zurück zum Zitat Nourhashémi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P, PAQUID study: Personnes Agées Quid: body mass index and incidence of dementia: the PAQUID study. Neurology. 2003, 60: 117-119. 10.1212/01.WNL.0000038910.46217.AA.CrossRefPubMed Nourhashémi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P, PAQUID study: Personnes Agées Quid: body mass index and incidence of dementia: the PAQUID study. Neurology. 2003, 60: 117-119. 10.1212/01.WNL.0000038910.46217.AA.CrossRefPubMed
18.
Zurück zum Zitat Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R: Measures of adiposity and dementia risk in elderly persons. Arch Neurol. 2007, 64: 392-398. 10.1001/archneur.64.3.392.PubMedCentralCrossRefPubMed Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R: Measures of adiposity and dementia risk in elderly persons. Arch Neurol. 2007, 64: 392-398. 10.1001/archneur.64.3.392.PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Roubenoff R, Auerbach S, DeCarli C, Wolf PA, Seshadri S: Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009, 302: 2565-2572. 10.1001/jama.2009.1836.PubMedCentralCrossRefPubMed Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Roubenoff R, Auerbach S, DeCarli C, Wolf PA, Seshadri S: Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA. 2009, 302: 2565-2572. 10.1001/jama.2009.1836.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Gustafson DR, Bäckman K, Waern M, Östling S, Guo X, Zandi PP, Mielke MM, Bengtsson C, Skoog I: Adiposity indicators and dementia over 32 years in Sweden. Neurology. 2009, 73: 1559-1566. 10.1212/WNL.0b013e3181c0d4b6.PubMedCentralCrossRefPubMed Gustafson DR, Bäckman K, Waern M, Östling S, Guo X, Zandi PP, Mielke MM, Bengtsson C, Skoog I: Adiposity indicators and dementia over 32 years in Sweden. Neurology. 2009, 73: 1559-1566. 10.1212/WNL.0b013e3181c0d4b6.PubMedCentralCrossRefPubMed
21.
Zurück zum Zitat Luchsinger JA, Biggs ML, Kizer JR, Barzilay J, Fitzpatrick A, Newman A, Longstreth WT, Lopez O, Siscovick D, Kuller L: Adiposity and cognitive decline in the cardiovascular health study. Neuroepidemiology. 2013, 40: 274-281. 10.1159/000345136.PubMedCentralCrossRefPubMed Luchsinger JA, Biggs ML, Kizer JR, Barzilay J, Fitzpatrick A, Newman A, Longstreth WT, Lopez O, Siscovick D, Kuller L: Adiposity and cognitive decline in the cardiovascular health study. Neuroepidemiology. 2013, 40: 274-281. 10.1159/000345136.PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Knopman DS, Edland SD, Cha RH, Petersen RC, Rocca WA: Incident dementia in women is preceded by weight loss by at least a decade. Neurology. 2007, 69: 739-746. 10.1212/01.wnl.0000267661.65586.33.CrossRefPubMed Knopman DS, Edland SD, Cha RH, Petersen RC, Rocca WA: Incident dementia in women is preceded by weight loss by at least a decade. Neurology. 2007, 69: 739-746. 10.1212/01.wnl.0000267661.65586.33.CrossRefPubMed
23.
Zurück zum Zitat Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA: Change in body mass index and risk of incident Alzheimer disease. Neurology. 2005, 65: 892-897. 10.1212/01.wnl.0000176061.33817.90.CrossRefPubMed Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA: Change in body mass index and risk of incident Alzheimer disease. Neurology. 2005, 65: 892-897. 10.1212/01.wnl.0000176061.33817.90.CrossRefPubMed
24.
Zurück zum Zitat Besser LM, Gill DP, Mosell SE, Brenowetz W, Moranus D, Kukull WA, Gustafson DR: Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer’s disease. Alzheimer Dis Assoc Disord. in press Besser LM, Gill DP, Mosell SE, Brenowetz W, Moranus D, Kukull WA, Gustafson DR: Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer’s disease. Alzheimer Dis Assoc Disord. in press
Metadaten
Titel
High adiposity: risk factor for dementia and Alzheimer’s disease?
verfasst von
Deborah R Gustafson
José A Luchsinger
Publikationsdatum
01.12.2013
Verlag
BioMed Central
Erschienen in
Alzheimer's Research & Therapy / Ausgabe 6/2013
Elektronische ISSN: 1758-9193
DOI
https://doi.org/10.1186/alzrt221

Weitere Artikel der Ausgabe 6/2013

Alzheimer's Research & Therapy 6/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.